CO6361950A2 - Composiciones, vacunas y metodos del virus del herpes del ganado bovino -1 - Google Patents

Composiciones, vacunas y metodos del virus del herpes del ganado bovino -1

Info

Publication number
CO6361950A2
CO6361950A2 CO11049498A CO11049498A CO6361950A2 CO 6361950 A2 CO6361950 A2 CO 6361950A2 CO 11049498 A CO11049498 A CO 11049498A CO 11049498 A CO11049498 A CO 11049498A CO 6361950 A2 CO6361950 A2 CO 6361950A2
Authority
CO
Colombia
Prior art keywords
vaccines
compositions
bhv
virus
herpes
Prior art date
Application number
CO11049498A
Other languages
English (en)
Inventor
Seetharaman Gopinath Raju
Richard Harland
Benedikt Kaufer
Nikolaus Osterrieder
Mayur Navnitbhai Patel
Ii Lee David Albee
Original Assignee
Novartis Ag
Univ Cornell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Univ Cornell filed Critical Novartis Ag
Publication of CO6361950A2 publication Critical patent/CO6361950A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16721—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La revelación tiene que ver de forma general con el tratamiento o prevención de enfermedades en el ganado. Más específicamente, la invención está dirigida a la producción y uso del virus del herpes del ganado bovino 1 (BHV-1) modificado y su utilización en las composiciones y vacunas que protegen al ganado de la infección del BHV-1 mientras que no suprime la respuesta inmunológica en el huésped. En un ejemplo, la invención está dirigida al uso del BHV-1 modificado, administrado con inmunógenos, ya sea a través de la co administración y/o a través de la administración en conjunto con vacunas, y el uso de estas vacunas para la protección del ganado de enfermedades. En un ejemplo, el uso del BHV-1 modificado en las composiciones administradas facilita una respuesta inmune a o contra los inmunógenos adicionales.
CO11049498A 2008-10-03 2011-04-20 Composiciones, vacunas y metodos del virus del herpes del ganado bovino -1 CO6361950A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19510208P 2008-10-03 2008-10-03

Publications (1)

Publication Number Publication Date
CO6361950A2 true CO6361950A2 (es) 2012-01-20

Family

ID=41354075

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11049498A CO6361950A2 (es) 2008-10-03 2011-04-20 Composiciones, vacunas y metodos del virus del herpes del ganado bovino -1

Country Status (12)

Country Link
US (1) US8637046B2 (es)
EP (1) EP2337582A1 (es)
JP (1) JP5723280B2 (es)
CN (1) CN102238961A (es)
AU (1) AU2009298490A1 (es)
BR (1) BRPI0920800A2 (es)
CA (1) CA2738664C (es)
CL (1) CL2011000742A1 (es)
CO (1) CO6361950A2 (es)
MX (1) MX2011003535A (es)
RU (1) RU2011117241A (es)
WO (1) WO2010039934A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8877211B2 (en) * 2011-06-27 2014-11-04 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Bovine herpes virus vaccine with multiple mutations
CN104640991B (zh) * 2012-07-04 2017-09-19 昆士兰州农渔林业部 重组低毒力1型牛疱疹病毒(BoHV‑1)疫苗载体
CN105343877B (zh) * 2015-11-26 2019-03-01 中国兽医药品监察所 一种5基因缺失伪狂犬病重组病毒活疫苗及其制备方法
US11083787B2 (en) 2015-12-03 2021-08-10 Board Of Supervisors Of The Louisiana State University And Agricultural And Mechanical College Bovine herpesvirus type 1 (BoHV-1) vector against bovine respiratory disease complex
EA202092164A1 (ru) * 2018-03-19 2021-02-10 Бёрингер Ингельхайм Ветмедика Гмбх Новый ehv с инактивированным ul18 и/или ul8
CN113817027A (zh) * 2021-07-13 2021-12-21 中国农业科学院兰州畜牧与兽药研究所 一种牛疱疹病毒Ⅰ型gE蛋白胞外区的原核可溶性表达方法
CN114107230B (zh) * 2021-11-29 2023-08-11 东北农业大学 一种牛疱疹病毒1型ul41缺失毒株及其获取方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593873A (en) * 1986-01-27 1997-01-14 Syntro Corporation Recombinant infectious bovine rhinotracheitis virus
US6410033B1 (en) * 1987-07-27 2002-06-25 Syntro Corporation Recombinant infectious bovine rhinotracheitis virus
US5998174A (en) * 1997-05-12 1999-12-07 University Of Pittsburgh Of The Commonwealth System Of Higher Education Multigene vectors
US6277621B1 (en) 1998-02-26 2001-08-21 Medigene, Inc. Artificial chromosome constructs containing foreign nucleic acid sequences
US7063851B2 (en) * 2000-04-12 2006-06-20 Biovex Limited Herpes viruses for immune modulation
NZ538394A (en) 2002-08-26 2008-06-30 Pfizer Prod Inc Vaccine for respiratory and reproductive system infections in cattles
US20040185056A1 (en) 2003-01-03 2004-09-23 Board Of Regents, University Of Nebraska-Lincoln Vaccines containing bovine herpesvirus 1 attenuated by mutation in latency-related gene
GB0406389D0 (en) 2004-03-22 2004-04-21 Istituto Superiore Di Sanito Recombinant herpes simplex virus and uses therefor
US20090068223A1 (en) * 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
BRPI0706709B8 (pt) 2006-01-26 2021-05-25 Pah Usa 15 Llc composição e processo para preparar a composição

Also Published As

Publication number Publication date
US20120034262A1 (en) 2012-02-09
CA2738664C (en) 2017-10-31
CL2011000742A1 (es) 2011-10-14
WO2010039934A1 (en) 2010-04-08
CA2738664A1 (en) 2010-04-08
RU2011117241A (ru) 2012-11-10
BRPI0920800A2 (pt) 2020-08-11
JP5723280B2 (ja) 2015-05-27
CN102238961A (zh) 2011-11-09
JP2012504417A (ja) 2012-02-23
AU2009298490A1 (en) 2010-04-08
US8637046B2 (en) 2014-01-28
EP2337582A1 (en) 2011-06-29
MX2011003535A (es) 2011-09-21

Similar Documents

Publication Publication Date Title
CO6361950A2 (es) Composiciones, vacunas y metodos del virus del herpes del ganado bovino -1
AR115939A2 (es) Composición que contiene palmitoil-etanolamida ultra-micronizada
CL2018000515A1 (es) Virus de la enfermedad de newcastle y usos de los mismos (divisional sol. 2532-2015)
ATE547118T1 (de) Rekombinanter koi-herpesvirus (khv) oder cyprinid-herpesvirus 3 (cyhv-3) und impfstoff zur prävention einer von khv/cyhv-3 bei cyprinus carpio carpio oder cyprinus carpio koi verursachten erkrankung
UY37998A (es) Agentes antivirales contra la hepatitis b
CR20150337A (es) Derivados de pirimidinona y su uso en el tratamiento, mejora o prevencion de una enfermedad viral
AR077629A1 (es) Mimetico de smac
CL2018001159A1 (es) Vacuna para adenovirus aviar (divisional de solicitud n° 358-2016)
GT201500020A (es) Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b
CL2012001215A1 (es) Sistema de expresion de un vector que comprende un primer y un segundo cassete de expresion donde el primer cassete codifica una gtp-ciclohidrolasa (gch1) y el segundo codifica una tirosina hidrolasa; vector; celula hospedera; uso del vector para preparar medicamento para tratar enfermedad asociada con catecolamina.
HN2011003011A (es) Composiciones sublinguales de dexmedetomidina y metodos de uso de ellas
WO2014205199A3 (en) Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potency
MY201105A (en) Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus
AR083395A1 (es) Derivado peptidico nmu (neuromedina u) con elevado efecto anorectico
DOP2011000268A (es) Vacuna inactivada del virus del dengue con un adjuvante libre de aluminio
CL2016002276A1 (es) Composiciones tópicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad
PH12021550479A1 (en) Dengue vaccine unit dose and administration thereof
AR077139A1 (es) Composiciones farmaceuticas utiles para tratar el vch
CO2021017317A2 (es) Células seguras e invisibles para el sistema inmunitario
CL2013001877A1 (es) Composicion inmunogenica que comprende un virus de diarrea viral bovina tipo 1b vivo modificado y un portador veterinario aceptable; vacuna que la comprende; y su uso para prevenir, tratar, manejar o aliviar uno o mas sintomas de una enfermedad causada por pestivirus.
EA201290373A1 (ru) Синергическая противовирусная композиция и ее применение
CO2019009000A2 (es) Combinaciones farmacéuticas para tratar cáncer
ECSP13012524A (es) Teobromina en combinación con un expectorante o un mucolítico para su uso en terapia
EA201791138A1 (ru) Фармацевтическая композиция, ее приготовление и применения
CO2019010029A2 (es) Compuestos de tipo imidazo[4,5-c]quinolin-2-ona deuterados y su uso en el tratamiento del cáncer

Legal Events

Date Code Title Description
FC Application refused